Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor
CompletedNCT01166477
Sociedad Andaluza de Enfermedades InfecciosasHIV Infection
Start: 2010-01-31End: 2011-12-31Updated: 2013-03-20